Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Lubetzki

Showing results (81-90 of 92) with videos related to

Pageof 10
Sort By:
Environment International|September 26, 2023
Deleterious functional consequences of perfluoroalkyl substances accumulation into the myelin sheathL Butruille, P Jubin, E Martin, et al.
European Journal of Neurology|May 16, 2000
Similar subcortical pattern of cognitive impairment in AIDS patients with and without dementiaS V Suarez, B Stankoff, L Conquy, et al.
European Journal of Neurology|October 26, 1999
Plasma and cerebrospinal fluid human immunodeficiency virus type-1 (HIV-1) RNA levels in HIV-related cognitive impairmentB Stankoff, V Calvez, S Suarez, et al.
Annals of Neurology|July 1, 1992
Ganglioside GD1b is the target antigen for a biclonal IgM in a case of sensory-motor axonal polyneuropathy: involvement of N-acetylneuraminic acid in the epitopeA B Younes-Chennoufi, J M Léger, J J Hauw, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|February 11, 2005
Edg8/S1P5: an oligodendroglial receptor with dual function on process retraction and cell survivalC Jaillard, S Harrison, B Stankoff, et al.
European Journal of Neurology|April 26, 2019
The cerebrospinal fluid CD4/CD8 ratio and interleukin-6 and -10 levels in neurosarcoidosis: a multicenter, pragmatic, comparative studyT Chazal, M Costopoulos, E Maillart, et al.
Neurology|January 10, 2001
Clinical and spectroscopic improvement in HIV-associated cognitive impairmentB Stankoff, A Tourbah, S Suarez, et al.
Journal of Neurology|May 28, 2023
A randomized double-blind placebo-controlled trial of low-dose interleukin-2 in relapsing-remitting multiple sclerosisC Louapre, M Rosenzwajg, M Golse, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|February 1, 1997
Therapeutic effect of mitoxantrone combined with methylprednisolone in multiple sclerosis: a randomised multicentre study of active disease using MRI and clinical criteriaG Edan, D Miller, M Clanet, et al.
Lancet (London, England)|October 10, 2009
Effect of glatiramer acetate on conversion to clinically definite multiple sclerosis in patients with clinically isolated syndrome (PreCISe study): a randomised, double-blind, placebo-controlled trialG Comi, V Martinelli, M Rodegher, et al.
Pageof 10

Showing results (81-90 of 92) with videos related to

Sort By:
Pageof 10
Environment International|September 26, 2023
Deleterious functional consequences of perfluoroalkyl substances accumulation into the myelin sheathL Butruille, P Jubin, E Martin, et al.
European Journal of Neurology|May 16, 2000
Similar subcortical pattern of cognitive impairment in AIDS patients with and without dementiaS V Suarez, B Stankoff, L Conquy, et al.
European Journal of Neurology|October 26, 1999
Plasma and cerebrospinal fluid human immunodeficiency virus type-1 (HIV-1) RNA levels in HIV-related cognitive impairmentB Stankoff, V Calvez, S Suarez, et al.
Annals of Neurology|July 1, 1992
Ganglioside GD1b is the target antigen for a biclonal IgM in a case of sensory-motor axonal polyneuropathy: involvement of N-acetylneuraminic acid in the epitopeA B Younes-Chennoufi, J M Léger, J J Hauw, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|February 11, 2005
Edg8/S1P5: an oligodendroglial receptor with dual function on process retraction and cell survivalC Jaillard, S Harrison, B Stankoff, et al.
European Journal of Neurology|April 26, 2019
The cerebrospinal fluid CD4/CD8 ratio and interleukin-6 and -10 levels in neurosarcoidosis: a multicenter, pragmatic, comparative studyT Chazal, M Costopoulos, E Maillart, et al.
Neurology|January 10, 2001
Clinical and spectroscopic improvement in HIV-associated cognitive impairmentB Stankoff, A Tourbah, S Suarez, et al.
Journal of Neurology|May 28, 2023
A randomized double-blind placebo-controlled trial of low-dose interleukin-2 in relapsing-remitting multiple sclerosisC Louapre, M Rosenzwajg, M Golse, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|February 1, 1997
Therapeutic effect of mitoxantrone combined with methylprednisolone in multiple sclerosis: a randomised multicentre study of active disease using MRI and clinical criteriaG Edan, D Miller, M Clanet, et al.
Lancet (London, England)|October 10, 2009
Effect of glatiramer acetate on conversion to clinically definite multiple sclerosis in patients with clinically isolated syndrome (PreCISe study): a randomised, double-blind, placebo-controlled trialG Comi, V Martinelli, M Rodegher, et al.
Pageof 10